Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin W Southern

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
The Cochrane Database of Systematic Reviews|March 3, 2023
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosisAisha A Aslam, Ian P Sinha, Kevin W Southern
The Cochrane Database of Systematic Reviews|March 16, 2012
Sodium channel blockers for cystic fibrosisElinor F Burrows, Kevin W Southern, Peadar G Noone
The Cochrane Database of Systematic Reviews|April 10, 2014
Sodium channel blockers for cystic fibrosisElinor F Burrows, Kevin W Southern, Peadar G Noone
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 8, 2010
Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screeningIsabelle Sermet-Gaudelus, Sarah J Mayell, Kevin W Southern, et al.
European Journal of Human Genetics : EJHG|March 8, 2022
Receiving results of uncertain clinical relevance from population genetic screening: systematic review & meta-synthesis of qualitative researchFaye Johnson, Fiona Ulph, Rhona MacLeod, et al.
The Cochrane Database of Systematic Reviews|February 27, 2024
Macrolide antibiotics (including azithromycin) for cystic fibrosisKevin W Southern, Arturo Solis-Moya, Dominiki Kurz, et al.
International Journal of Neonatal Screening|January 25, 2022
International Approaches to Management of CFTR-Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive DiagnosisJane Chudleigh, Jürg Barben, Clement L Ren, et al.
The Cochrane Database of Systematic Reviews|December 17, 2020
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)Kevin W Southern, Jared Murphy, Ian P Sinha, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Macrolide antibiotics for cystic fibrosisKevin W Southern, Pierre M Barker, Arturo Solis-Moya, et al.
International Journal of Neonatal Screening|October 19, 2020
Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic FibrosisRachael E Armstrong, Lucy Frith, Fiona M Ulph, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
The Cochrane Database of Systematic Reviews|March 3, 2023
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosisAisha A Aslam, Ian P Sinha, Kevin W Southern
The Cochrane Database of Systematic Reviews|March 16, 2012
Sodium channel blockers for cystic fibrosisElinor F Burrows, Kevin W Southern, Peadar G Noone
The Cochrane Database of Systematic Reviews|April 10, 2014
Sodium channel blockers for cystic fibrosisElinor F Burrows, Kevin W Southern, Peadar G Noone
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 8, 2010
Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screeningIsabelle Sermet-Gaudelus, Sarah J Mayell, Kevin W Southern, et al.
European Journal of Human Genetics : EJHG|March 8, 2022
Receiving results of uncertain clinical relevance from population genetic screening: systematic review & meta-synthesis of qualitative researchFaye Johnson, Fiona Ulph, Rhona MacLeod, et al.
The Cochrane Database of Systematic Reviews|February 27, 2024
Macrolide antibiotics (including azithromycin) for cystic fibrosisKevin W Southern, Arturo Solis-Moya, Dominiki Kurz, et al.
International Journal of Neonatal Screening|January 25, 2022
International Approaches to Management of CFTR-Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive DiagnosisJane Chudleigh, Jürg Barben, Clement L Ren, et al.
The Cochrane Database of Systematic Reviews|December 17, 2020
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)Kevin W Southern, Jared Murphy, Ian P Sinha, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Macrolide antibiotics for cystic fibrosisKevin W Southern, Pierre M Barker, Arturo Solis-Moya, et al.
International Journal of Neonatal Screening|October 19, 2020
Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic FibrosisRachael E Armstrong, Lucy Frith, Fiona M Ulph, et al.
Pageof 12